China Biologic Products Inc (NASDAQ:CBPO)
| 23.37 Data as of 3:59pm ET |  +0.67 / +2.95%Today’s Change | 8.00 Today|||52-Week Range 31.15 | +43.29% Year-to-Date |
Latest CBPO News | Press Releases
No recent news for China Biologic Products Inc.
Today’s Trading
| Previous close | 22.70 |
| Today’s open | 22.92 |
| Day’s range | 22.80 - 23.50 |
| Volume | 9,107 |
| Average volume (3 months) | 33,412 |
| Market cap | $609.4M |
| Dividend yield | -- |
Data as of 3:59pm ET, 06/18/2013
Growth & Valuation
| Earnings growth (last year) | +136.99% |
| Earnings growth (this year) | +3.91% |
| Earnings growth (next 5 years) | +30.00% |
| Revenue growth (last year) | +20.72% |
| P/E ratio | 13.7 |
| Price/Sales | 2.31 |
| Price/Book | 3.09 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MACKMerrimack Pharmaceut... | +0.01 | +0.16% |
| OREXOrexigen Therapeutic... | +0.10 | +1.59% |
| ARRYArray Biopharma Inc | -0.13 | -2.55% |
| LGNDLigand Pharmaceutica... | +1.11 | +3.53% |
Data as of 4:00pm ET, 06/18/2013
Financials
| Next reporting date | August 19, 2013 |
| EPS forecast (this quarter) | $0.48 |
| Annual revenue (last year) | $184.8M |
| Annual profit (last year) | $45.2M |
| Net profit margin | 24.47% |
Profile
Sector Health Technology |
Industry Biotechnology |
Executive Chairman, President & CEO David Xiaoying Gao, MBA |
Chief Financial Officer Ming Yang |
Corporate headquarters Beijing, Beijing |
Forecasts
